Only logged in customers who have purchased this product may leave a review.
Livagen 20mg
Research Grade Peptide
- Research Grade
- 99% Purity
- Third-Party Verified
Reference Strength: 20mg
R799,00
Chemical Name / Amino Acid Sequence: Lys-Glu-Asp-Ala
Availability: In stock
SKU: LI20
Livagen 20mg
R799,00
Livagen (Lys-Glu-Asp-Ala) is a synthetic tetrapeptide bioregulator investigated for its potential effects on cellular homeostasis, healthy ageing and regenerative processes.
Availability: In stock
Included with your purchase
Each qualifying product includes 3ml of 0.9% Benzyl Alcohol Bacteriostatic Water.
Complimentary Purchase Kit
Every qualifying vial includes a complimentary purchase kit at no additional cost.
Research Overview
About Livagen 20mg
Livagen has been studied for peptidase inhibition and epigenetic modulation in ageing tissues. Experimental research suggests effects on gene expression and cellular maintenance, although standardized human dosing has not been established.
How It Works in Research
Livagen has been investigated for inhibition of enkephalin-degrading enzymes and epigenetic modulation. Preclinical studies suggest it may influence chromatin structure, gene expression and cellular regenerative processes while supporting cellular homeostasis.
Research Applications
• Healthy ageing • Cellular repair • Gene expression • Regenerative biology • Enkephalin metabolism • Epigenetics
Researchers investigate Livagen because it may help support normal cellular repair and healthy ageing by influencing gene regulation and enzyme activity.
Product Specifications
- Product Name: Livagen
- Alternate Chemical Name: Lys-Glu-Asp-Ala
- Reference Strength: 20 mg
- Amino Acid Sequence: Lys-Glu-Asp-Ala
- Appearance: White to off-white lyophilised powder
Research Information
- Purity Standard: ≥98% (HPLC)
- Category: Tetrapeptide Bioregulator
- Reconstitution: 3.0 mL bacteriostatic water
- Final Concentration: 6.67 mg/mL
- Storage: 2–8°C after reconstitution
Mechanism of Action
Livagen has been investigated for inhibition of enkephalin-degrading enzymes and epigenetic modulation. Preclinical studies suggest it may influence chromatin structure, gene expression and cellular regenerative processes while supporting cellular homeostasis.
Potential Benefits in Research
Support for cellular homeostasis.
- May promote healthy ageing through epigenetic regulation.
- May inhibit enkephalin-degrading enzymes, prolonging endogenous enkephalin activity.
- Support for regenerative processes in ageing tissues.
- May influence gene expression and chromatin remodelling.
- May support normal cellular structure and tissue maintenance.
- May support healthy digestive enzyme activity in ageing models.
Safety Profile
Support for cellular homeostasis.
- May promote healthy ageing through epigenetic regulation.
- May inhibit enkephalin-degrading enzymes, prolonging endogenous enkephalin activity.
- Support for regenerative processes in ageing tissues.
- May influence gene expression and chromatin remodelling.
- May support normal cellular structure and tissue maintenance.
- May support healthy digestive enzyme activity in ageing models.
Research Applications
Healthy ageing
Cellular repair
Gene expression
Regenerative biology
Enkephalin metabolism
Epigenetics
Educational protocol only; no standardized human dosing exists.
REFERENCE RECONSTITUTION INFORMATION
Educational protocol only; no standardized human dosing exists.
Always follow sterile preparation techniques when handling research peptides.
Educational protocol only; no standardized human dosing exists.
General Preparation
Slowly add bacteriostatic water down the vial wall. Allow the powder to dissolve naturally and gently swirl until clear. Do not shake vigorously.
- Slowly add bacteriostatic water down the vial wall. Allow the powder to dissolve naturally and gently swirl until clear. Do not shake vigorously.
LIVAGEN (20MG)- RECONSTITUTION TABLES
Reference Handling Information
Reference information for laboratory handling of Livagen 20mg.
- Use a new sterile insulin syringe for each injection.
- Rotate injection sites.
- Inject slowly.
- Record daily dose and injection site.
- Educational protocol only; no standardized human dosing exists. Reconstitute with 3.0 mL bacteriostatic water to achieve approximately 6.67 mg/mL. At this concentration, 1 U-100 unit equals approximately 0.0667 mg.
Reference Parameters (Dosing Protocol)
| Week | Daily Dose (mg) | U-100 Units | Volume |
|---|---|---|---|
| Weeks 1–2 | 0.5 mg | 7.5 units | 0.075 mL |
| Weeks 3–4 | 1.0 mg | 15 units | 0.15 mL |
| Weeks 5–6 | 1.5 mg | 22.5 units | 0.225 mL |
| Weeks 7–12 | 2.0 mg | 30 units | 0.30 mL |
For laboratory research only.
Experimental Study Period
STUDY PERIOD
8–12 weeks (optional extension to 16 weeks)
RESEARCH CONTEXT
Support cellular homeostasis and regenerative processes in ageing tissues.
Daily subcutaneous injections for 8–12 weeks (optional extension to 16 weeks).
View Certificate of Analysis
View Certificate of Analysis Each batch of Livagen is independently tested by third-party laboratories. Download the Certificate of Analysis to verify purity, identity, and quality.
99%
Verified Purity
3rd Party
Lab Tested
Certified
Quality Assured
Related products
-
Skin, Hormonal & Vitality Research
GHK-Cu
Price range: R599,00 through R799,00 Select options This product has multiple variants. The options may be chosen on the product page
Reviews
There are no reviews yet.
Only logged in customers who have purchased this product may leave a review.
PURE PERFORMANCE LABS
Recommended Research Products
Explore related compounds commonly viewed alongside this product.
FOR RESEARCH PURPOSES ONLY
This product is intended for research and laboratory use only. Always consult qualified researchers and follow appropriate safety protocols.
Reviews
There are no reviews yet.